483
WestChina-Frontier PharmaTech Co, LtdFDA 483 - WestChina-Frontier PharmaTech Co, Ltd - July 25, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of WestChina-Frontier PharmaTech Co., Ltd. in Chengdu, China, revealed significant Good Laboratory Practice (GLP) deficiencies. The firm failed to ensure timely archiving of study materials and related correspondence. Additionally, the quality assurance unit did not properly document deviations from approved protocols.
Open in Dashboard
ID · 82e1ae02-e37d-42ba-a02d-2f7726145dd8